公司資料
Ocean Biomedical 股價、新聞與催化劑
- 股票代碼:
- OCEA
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年8月17日
—
市值
股價為何變動
As of Aug 17, 2026, OCEA was little changed and closed at $0.0010. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Ocean Biomedical is a biotech company that has pursued multiple discovery and development directions, often with a focus on novel cancer and inflammatory disease concepts. Its identity has been shaped by platform ambition and capital markets evolution.
所在地與產業分類
Ocean Biomedical is headquartered in the United States and listed on NASDAQ. It sits in small-cap biotechnology.
商業模式特徵
The company depends on strategic focus, scientific validation, and capital efficiency. Investors usually watch corporate restructuring, pipeline prioritization, and funding.
生技產業定位
Ocean Biomedical occupies a speculative small-cap biotech niche. The stock is driven more by strategy and financing than by mature commercial execution.
未來催化劑
- Ocean Biomedical is largely a legacy / closeout story, so the catalysts are any strategic or asset-resolution update rather than a live pipeline milestone. The market is focused on residual value.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。